With reference to PD-1 expression within lymphocyte subsets, slight differences in response to anti-PD-1 blockage seem to be associated with differential expression of PD-1 in tumor-associated lymphocytes, predominantly in CD4+ T cells [41]. Here, CD4 is linked to neoplasm.